Thromb Haemost 1998; 79(02): 452-453
DOI: 10.1055/s-0037-1615015
Scientific and Standardization Committee Communication
Schattauer GmbH

Small Deletion/Insertion Mutations within Poly-A Runs of the Factor VIII Gene Mitigate the Severe Haemophilia A Phenotype

J. Oldenburg
1   From the Department of Human Genetics, University of Würzburg, Biozentrum, Würzburg
2   From the Department of Experimental Haematology and Transfusion Medicine, University of Bonn, Bonn, Germany
,
J. Schröder
1   From the Department of Human Genetics, University of Würzburg, Biozentrum, Würzburg
,
C. Schmitt
2   From the Department of Experimental Haematology and Transfusion Medicine, University of Bonn, Bonn, Germany
,
H. H. Brackmann
2   From the Department of Experimental Haematology and Transfusion Medicine, University of Bonn, Bonn, Germany
,
R. Schwaab
2   From the Department of Experimental Haematology and Transfusion Medicine, University of Bonn, Bonn, Germany
› Author Affiliations
Further Information

Publication History

Received 14 August 1997

Accepted 01 October 1997

Publication Date:
08 December 2017 (online)

 

 
  • References

  • 1 Young M, Inaba H, Hoyer LW, Higuchi M, Kazazian Jr HH, Antonarakis SE. Partial correction of a severe molecular defect in hemophilia A, because of errors during expression of the factor VIII gene. Am J Hum Genet 1998; 60: 565-73.
  • 2 Becker J, Schwaab R, Möller-Taube A, Schwaab U, Schmidt W, Brackmann HH, Grimm T, Olek K, Oldenburg J. Characterization of the factor VIII defect in 147 patients with sporadic hemophilia A: Family studies indicate a mutation type dependent sex ratio of mutation frequencies. Am J Hum Genet 1996; 58: 657-70.
  • 3 Nichols WC, Amano K, Cacheris PM, Figueiredo MS, Michaelides K, Schwaab R, Hoyer L, Kaufman RJ, Ginsburg D. Moderation of hemophilia A phenotype by the factor V R506Q mutations. Blood 1996; 88: 1183-7.
  • 4 Pittman DD, Alderman EM, Tomkinson KN, Wang JH, Giles AR, Kaufman RJ. Biochemical, immunological, and in vivo functional characterization of the B-domain-deleted factor VIII. Blood 1993; 81: 2925-35.
  • 5 Schwaab R, Brackmann HH, Meyer C, Seehafer J, Kirchgesser M, Haack A, Olek K, Tuddenham EGD, Oldenburg J. Haemophilia A: Mutation type determines risk of inhibitor formation. Thromb Haemost 1995; 74: 1402-6.
  • 6 Wacey AI, Kemball-Cook G, Kazazian HH, Antonarakis SE, Schwaab R, Lindley P, Tuddenham EGD. The haemophilia A mutation search test and resource site, home page of the factor VIII mutation database: HAMSTeRS. Nuc Acid Res 1996; 24: 100-2.
  • 7 Egli H. Laboratoriumsdiagnostik der Hämophilen. Deutsch Med J 1968; 14: 495-9.
  • 8 Schmitt C, Oldenburg J, Haack A, Poller J, Brackmann HH, Schwaab R. Investigation of factor VIII-antigen levels of patients with haemophilia A by a new highly sensitive enzyme linked immunosorbent assay (ELISA). Thromb Haemost 1998; Suppl: 31.
  • 9 Hartert H. Blutgerinnungsstudien mit der Thrombelastographie, einem neuen Untersuchungsverfahren. Klin Wsch 1948; 26: 577.